Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 11, Pages e81264
Publisher
Public Library of Science (PLoS)
Online
2013-11-22
DOI
10.1371/journal.pone.0081264
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
- (2015) Sílvia Cufí et al. Oncotarget
- Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
- (2015) Ramandeep Rattan et al. NEOPLASIA
- Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer
- (2013) Se-Lim Kim et al. CANCER LETTERS
- Metformin and cancer
- (2013) Christos V. Rizos et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Increased Risk of Gastrointestinal Malignancy in Patients with Diabetes Mellitus and Correlations with Anti-Diabetes Drugs: A Nationwide Population-based Study in Taiwan
- (2013) Chun-Chih Chiu et al. INTERNAL MEDICINE
- AMPK Activators Suppress Cervical Cancer Cell Growth through Inhibition of DVL3 Mediated Wnt/β-Catenin Signaling Activity
- (2013) H. T. Kwan et al. PLoS One
- CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2013) Shicai Chen et al. PLoS One
- Low Concentrations of Metformin Selectively Inhibit CD133+ Cell Proliferation in Pancreatic Cancer and Have Anticancer Action
- (2013) Shanmiao Gou et al. PLoS One
- The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
- (2013) Hyun Hee Chung et al. Diabetes & Metabolism Journal
- Metformin selectively affects human glioblastoma tumor-initiating cell viability
- (2012) Roberto Würth et al. CELL CYCLE
- Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects
- (2012) M A Pierotti et al. ONCOGENE
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- CD133 Is a Useful Surrogate Marker for Predicting Chemosensitivity to Neoadjuvant Chemotherapy in Breast Cancer
- (2012) Naoki Aomatsu et al. PLoS One
- 5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells
- (2012) Yan-Hong Deng et al. Chinese Journal of Cancer
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
- (2011) Meei-Shyuan Lee et al. BMC CANCER
- Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis
- (2011) Z.-J. Zhang et al. DIABETES CARE
- The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
- (2011) Jin Ha Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Cα-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activat
- (2010) Yong P Hwang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
- (2010) K. Hosono et al. Cancer Prevention Research
- CD133 and nuclear β-catenin: The marker combination to detect high risk cases of low stage colorectal cancer
- (2009) David Horst et al. EUROPEAN JOURNAL OF CANCER
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2008) D. M. Nathan et al. DIABETES CARE
- Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation
- (2008) Liqin Zhu et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started